Coverage
-
January 09, 2024
The former healthcare CEO at the center of a novel insider trading indictment has moved to dismiss the criminal charges against him, arguing prosecutors failed to allege that shareholders were kept in the dark about a faltering customer relationship while the executive prepared to sell off millions of dollars worth of stock.
2 other articles on this case.
View all »